drugset / Trial / NCT03291990

5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme

NCT03291990

NaSingle-groupOpen-labelOther

Summary

This investigation is not only to develop an improved radiation/temozolomide approach, but also develop a regimen with potential to form the basis of better combined therapy with immune based treatments.

Timeline

Start
2017-10-18
Primary completion
2020-08-19
Completion
2020-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule

Indications